
Dr Göran Ando
Dr Göran Ando MD, is the retired Chairman of the Board of Directors of Novo Nordisk A/S. Göran is Chairman of Nouscom, Chairman of Tessa Therapeutics Ltd, Chairman of Eyepoint Pharmaceuticals Inc and the Chairman of Nanexa AB. He is a Director of Paraxel International Corp. Göran also serves as Senior Advisor to Essex Woodlands Health Ventures LLC, an Advisor to Edbi Pte Ltd, Singapore and is Non-Executive Director of EUSA Pharma (UK) Ltd and Selectra Biosciences Inc.